• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Editorial of Special Issue "The Biological Fate of Drug Nanocarriers".

作者信息

Wu Wei, Li Tonglei, Zheng Ying

机构信息

Key Laboratory of Smart Drug Delivery of MOE, School of Pharmacy, Fudan University, Shanghai 201203, China.

Center for Medical Research and Innovation, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai 201399, China.

出版信息

Acta Pharm Sin B. 2021 Apr;11(4):850-851. doi: 10.1016/j.apsb.2021.04.004. Epub 2021 May 1.

DOI:10.1016/j.apsb.2021.04.004
PMID:33996403
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8105767/
Abstract
摘要

相似文献

1
Editorial of Special Issue "The Biological Fate of Drug Nanocarriers".《“药物纳米载体的生物学命运”特刊社论》
Acta Pharm Sin B. 2021 Apr;11(4):850-851. doi: 10.1016/j.apsb.2021.04.004. Epub 2021 May 1.
2
Editorial of Special Issue "Surface-Functionalized Nanoparticles as Drug Carriers".特刊编辑寄语：表面功能化纳米颗粒作为药物载体
Int J Mol Sci. 2019 Dec 17;20(24):6352. doi: 10.3390/ijms20246352.
3
The effects of protein corona on in vivo fate of nanocarriers.蛋白质冠层对纳米载体体内命运的影响。
Adv Drug Deliv Rev. 2022 Jul;186:114356. doi: 10.1016/j.addr.2022.114356. Epub 2022 May 17.
4
Degradation of Drug Delivery Nanocarriers and Payload Release: A Review of Physical Methods for Tracing Nanocarrier Biological Fate.药物递送纳米载体的降解与载药量释放：纳米载体生物学命运追踪物理方法综述
Pharmaceutics. 2021 May 21;13(6):770. doi: 10.3390/pharmaceutics13060770.
5
Biopharmaceutical parameters to consider in order to alter the fate of nanocarriers after oral delivery.口服给予后改变纳米载体命运需要考虑的生物制药参数。
Nanomedicine (Lond). 2010 Feb;5(2):287-306. doi: 10.2217/nnm.09.110.
6
Lipid-based Nanocarriers for Cancer and Tumor Treatment.用于癌症和肿瘤治疗的基于脂质的纳米载体。
Curr Pharm Des. 2020;26(34):4272-4276. doi: 10.2174/1381612826666200720235752.
7
Effect of physicochemical and surface properties on in vivo fate of drug nanocarriers.药物纳米载体体内命运的理化性质和表面特性的影响。
Adv Drug Deliv Rev. 2019 Mar 15;143:3-21. doi: 10.1016/j.addr.2019.01.002. Epub 2019 Jan 11.
8
Environment-responsive aza-BODIPY dyes quenching in water as potential probes to visualize the in vivo fate of lipid-based nanocarriers.环境响应型氮杂 BODIPY 染料在水中的猝灭作用可作为潜在的探针，用于可视化基于脂质的纳米载体的体内命运。
Nanomedicine. 2015 Nov;11(8):1939-48. doi: 10.1016/j.nano.2015.06.013. Epub 2015 Jul 15.
9
The intracellular fate and transport mechanism of shape, size and rigidity varied nanocarriers for understanding their oral delivery efficiency.不同形状、大小和刚性的纳米载体的细胞内命运和运输机制，以了解它们的口服递送效率。
Biomaterials. 2023 Mar;294:121995. doi: 10.1016/j.biomaterials.2023.121995. Epub 2023 Jan 6.
10
The immune-stealth polymeric coating on drug delivery nanocarriers: In vitro engineering and in vivo fate.载药纳米载体的免疫隐身聚合物涂层：体外工程与体内命运。
J Biomater Appl. 2023 Aug;38(2):159-178. doi: 10.1177/08853282231185352. Epub 2023 Jul 22.

引用本文的文献

1
Enteral Route Nanomedicine for Cancer Therapy.肠内途径的癌症治疗纳米医学。
Int J Nanomedicine. 2024 Sep 25;19:9889-9919. doi: 10.2147/IJN.S482329. eCollection 2024.
2
Current research trends of nanomedicines.纳米药物的当前研究趋势。
Acta Pharm Sin B. 2023 Nov;13(11):4391-4416. doi: 10.1016/j.apsb.2023.05.018. Epub 2023 May 20.
3
The feasibility of oral targeted drug delivery: Gut immune to particulates?口服靶向给药的可行性：肠道对微粒免疫吗？

本文引用的文献

1
Intracellular aggregation of peptide-reprogrammed small molecule nanoassemblies enhances cancer chemotherapy and combinatorial immunotherapy.肽重编程小分子纳米组装体的细胞内聚集增强癌症化疗和联合免疫疗法。
Acta Pharm Sin B. 2021 Apr;11(4):1069-1082. doi: 10.1016/j.apsb.2020.06.013. Epub 2020 Jun 29.
2
dissolution of poorly water-soluble drugs: Proof of concept based on fluorescence bioimaging.难溶性药物的溶解：基于荧光生物成像的概念验证
Acta Pharm Sin B. 2021 Apr;11(4):1056-1068. doi: 10.1016/j.apsb.2020.08.002. Epub 2020 Aug 13.
3
Uptake and trafficking of different sized PLGA nanoparticles by dendritic cells in imiquimod-induced psoriasis-like mice model.
Acta Pharm Sin B. 2023 Jun;13(6):2544-2558. doi: 10.1016/j.apsb.2022.10.020. Epub 2022 Oct 29.
4
Nanovesicles-Mediated Drug Delivery for Oral Bioavailability Enhancement.基于纳米囊泡的药物传递系统用于提高口服生物利用度。
Int J Nanomedicine. 2022 Oct 17;17:4861-4877. doi: 10.2147/IJN.S382192. eCollection 2022.
5
The long-circulating effect of pegylated nanoparticles revisited simultaneous monitoring of both the drug payloads and nanocarriers.聚乙二醇化纳米颗粒的长效循环效应再探讨：药物负载量与纳米载体的同步监测
Acta Pharm Sin B. 2022 May;12(5):2479-2493. doi: 10.1016/j.apsb.2021.11.016. Epub 2021 Nov 18.
6
Recent Advances in the Gastrointestinal Fate of Organic and Inorganic Nanoparticles in Foods.食品中有机和无机纳米颗粒的胃肠道命运研究新进展
Nanomaterials (Basel). 2022 Mar 27;12(7):1099. doi: 10.3390/nano12071099.
咪喹莫特诱导的银屑病样小鼠模型中树突状细胞对不同大小聚乳酸-羟基乙酸共聚物纳米颗粒的摄取与转运
Acta Pharm Sin B. 2021 Apr;11(4):1047-1055. doi: 10.1016/j.apsb.2020.11.008. Epub 2020 Nov 20.
4
Impact of particle size and pH on protein corona formation of solid lipid nanoparticles: A proof-of-concept study.粒径和pH值对固体脂质纳米粒蛋白质冠形成的影响：一项概念验证研究。
Acta Pharm Sin B. 2021 Apr;11(4):1030-1046. doi: 10.1016/j.apsb.2020.10.023. Epub 2020 Oct 29.
5
Intracellular uptake of nanocrystals: Probing with aggregation-induced emission of fluorescence and kinetic modeling.纳米晶体的细胞内摄取：基于聚集诱导荧光发射及动力学模型的探究
Acta Pharm Sin B. 2021 Apr;11(4):1021-1029. doi: 10.1016/j.apsb.2020.09.017. Epub 2020 Oct 14.
6
Gastrointestinal lipolysis and trans-epithelial transport of SMEDDS oral route.胃肠道脂肪分解及自微乳药物传递系统的跨上皮转运——口服途径
Acta Pharm Sin B. 2021 Apr;11(4):1010-1020. doi: 10.1016/j.apsb.2021.03.006. Epub 2021 Mar 10.
7
The biological fate of the polymer nanocarrier material monomethoxy poly(ethylene glycol)--poly(d,l-lactic acid) in rat.聚合物纳米载体材料单甲氧基聚（乙二醇）-聚（d，l-乳酸）在大鼠体内的生物学命运。
Acta Pharm Sin B. 2021 Apr;11(4):1003-1009. doi: 10.1016/j.apsb.2021.02.018. Epub 2021 Mar 4.
8
testing of mucus-permeating nanoparticles for oral insulin delivery using as a model under hyperglycemic conditions.在高血糖条件下，以[具体内容缺失]为模型对用于口服胰岛素递送的黏液渗透纳米颗粒进行测试。
Acta Pharm Sin B. 2021 Apr;11(4):989-1002. doi: 10.1016/j.apsb.2021.02.020. Epub 2021 Mar 1.
9
The contribution of absorption of integral nanocrystals to enhancement of oral bioavailability of quercetin.完整纳米晶体的吸收对槲皮素口服生物利用度提高的贡献。
Acta Pharm Sin B. 2021 Apr;11(4):978-988. doi: 10.1016/j.apsb.2021.02.015. Epub 2021 Feb 25.
10
The role of caveolin-1 in the biofate and efficacy of anti-tumor drugs and their nano-drug delivery systems.小窝蛋白-1在抗肿瘤药物及其纳米药物递送系统的生物命运和疗效中的作用。
Acta Pharm Sin B. 2021 Apr;11(4):961-977. doi: 10.1016/j.apsb.2020.11.020. Epub 2020 Nov 28.